Universal Health Services, Inc. (UHS) Earnings Call Transcripts

Universal Health Services, Inc.'s Latest Earnings Call - Q2 FY2026

In Q2 2026, Universal Health Services (UHS) reported adjusted EPS of $5.98, up 12% year-over-year, but adjusted EBITDA less NCI fell short of expectations due to increased liability reserves and slower ramp-up of new facilities. Revenue growth was 7%, with management adjusting full-year guidance to reflect a more conservative outlook for volume growth in both Acute Care and Behavioral Health segments. The company remains committed to share repurchases, accelerating to $320 million in Q2, signaling confidence in its long-term value despite operational challenges.

Reported metrics

Guidance from management

Management updated its 2026 guidance to reflect approximately 7% revenue growth and adjusted EBITDA less NCI in the range of $2.61 billion to $2.72 billion, a decrease of about $50 million from prior forecasts.

What management said

So I think the answer, Matthew, is we're not certain what the impact of the 2026 approved program would be, which is partly why we have not either recorded any benefit in '26 or included it in our guidance. Obviously, if the program is approved, we will record it and we'll be benefited by that. As far as other programs, there was a recent approval of a California program that we've been recording. I don't think we ...

No. I think, Ryan, that's -- again, that's not a new phenomenon. I think the issue is that for a good portion of the population who don't have their own primary care doctors, they use hospital ERs as their primary care doctors. And as a consequence, those visits are not necessarily sort of traditionally emergent. And so we can -- while we continue to see a lot of acutely ill patients in our ERs, we also continue to s...

What analysts pressed on

Analysts expressed concerns regarding the slower-than-expected ramp-up of new facilities and the impact of increased liability reserves on profitability. There were also questions about the sustainability of Acute Care volumes amid shifts to outpatient settings.

Main topics on the call

• Revenue Growth and Guidance Adjustment — UHS reported a revenue growth of 7% for Q2 2026 but adjusted its full-year guidance for volume growth downwards, now expecting Acute Care adjusted admissions to grow between 1.5% to 2.5%. Management stated, "we believe c...
• Acute Care Volume Trends — Adjusted admissions in Acute Care hospitals increased by 2.9% year-over-year, with emergency department visits up 4%. However, management noted, "we're seeing continued shift of certain elective and outpatient procedures...
• Behavioral Health Segment Performance — The Behavioral Health segment saw a 7.4% increase in same-facility net revenue, but the adjusted patient day growth was only 1.5% year-to-date. Management highlighted that outpatient demand is growing but at a slower pac...
• Share Repurchase Strategy — UHS accelerated its share repurchase program, buying back $320 million worth of shares in Q2 compared to $127 million in Q1. Management indicated that the recent dislocation in share price represents a compelling opportu...

Read the full Universal Health Services, Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 83 Universal Health Services, Inc. earnings call transcripts on record, spanning January 13, 2020 to July 28, 2026. Based on this history, Universal Health Services, Inc. reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

UHS

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

83

First call

January 13, 2020

Most recent

July 28, 2026

Reporting cadence

quarterly